Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

NCT: NCT05677100 · RECRUITING

NCT IDNCT05677100
StatusRECRUITING
Start Date2023-08-23
Completion2027-08

Brief Summary

Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejection fraction) will be enrolled and randomized 1:1 to either the Aortix system or standard of care medical management.

Frequently Asked Questions

What is Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure?

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure is a clinical trial registered under NCT05677100. Current status: RECRUITING.

What is the status of NCT05677100?

The current status of NCT05677100 (Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure) is: RECRUITING.

When did Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure start?

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure started on 2023-08-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑